Comments: NJ A2022 | 2020-2021 | Regular Session

Bill Title: Prohibits pre-approval or precertification of cancer treatments, tests, procedures and prescription drugs covered under health benefits or prescription drug benefits plans.

Spectrum: Slight Partisan Bill (Democrat 5-3)

Status: (Introduced - Dead) 2020-01-14 - Introduced, Referred to Assembly Health Committee [A2022 Detail]

Text: Latest bill text (Introduced) [HTML]

PolitiCorps Conversations

Start PolitiCorps Debate
TitlePolitiCorpsAccessCommentsViewsLast Post
There are no visible public or private PolitiCorps discussions concerning the 2020 New Jersey A2022 at this time.

Social Comments on NJ A2022

feedback